|
|
Blood, 15 September 2005, Vol. 106, No. 6, pp. 2050-2058.
Prepublished online as a Blood First Edition Paper on June 2, 2005; DOI 10.1182/blood-2005-03-0921.
Previous Article | Next Article 
Submitted March 7, 2005
Accepted May 18, 2005
Anti-neutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo
Mark A Little, C L Smyth, Rashmi Yadav, Lyn Ambrose, H T Cook, Sussan Nourshargh, and Charles D Pusey*
The Eric Bywaters Centre for Vascular Inflammation, Division of Medicine, Imperial College London, Hammersmith Campus, London, United Kingdom; Renal Section, Division of Medicine, Imperial College London, Hammersmith Campus, London, United Kingdom
Renal Section, Division of Medicine, Imperial College London, Hammersmith Campus, London, United Kingdom
The Eric Bywaters Centre for Vascular Inflammation, Division of Medicine, Imperial College London, Hammersmith Campus, London, United Kingdom
Department of Histopathology, Division of Medicine, Imperial College London, Hammersmith Campus, London, United Kingdom
* Corresponding author; email: c.pusey{at}imperial.ac.uk.
Systemic small vessel vasculitis is associated with anti-neutrophil cytoplasm antibodies (ANCA). Whilst there is mounting in vitro evidence to suggest that ANCA are capable of enhancing leukocyte-endothelial interactions, no in vivo evidence for this has been provided. In this study a novel rat model of ANCA-associated experimental autoimmune vasculitis (EAV), induced by immunisation with human MPO, was used to analyse directly the potential effect of ANCA on leukocyte-venular wall interactions in vivo as observed by intravital microscopy. These rats developed anti-MPO antibodies directed against rat leukocytes, showed pathological evidence of small vessel vasculitis, and had enhanced leukocyte adhesion and transmigration in response to the chemokine Gro (CXCL1). Passive transfer of immunoglobulin from rats with EAV to naive rats conferred enhanced adhesion and transmigration responses in the recipients. Furthermore, rats with EAV and recipients of ANCA-positive immunoglobulin developed extensive microvascular injury, as manifested by mesenteric haemorrhage, in response to CXCL1. This study provides the first direct in vivo evidence for the ability of ANCA to enhance leukocyte-endothelial interactions and cause microvascular haemorrhage, thereby providing a mechanism by which ANCA could exert pathogenic effects in systemic vasculitis.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Watching ANCAs work
- Ingeborg M. Bajema
Blood 2005 106: 1889-1890.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
M. Chen and C. G. M. Kallenberg
Novel territory for neutrophils in the pathogenesis of ANCA-associated vasculitides
Nephrol. Dial. Transplant.,
December 1, 2009;
24(12):
3618 - 3620.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Gomez-Puerta and X. Bosch
Anti-Neutrophil Cytoplasmic Antibody Pathogenesis in Small-Vessel Vasculitis: An Update
Am. J. Pathol.,
November 1, 2009;
175(5):
1790 - 1798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Gomez-Puerta, J. Hernandez-Rodriguez, A. Lopez-Soto, and X. Bosch
Antineutrophil Cytoplasmic Antibody-Associated Vasculitides and Respiratory Disease
Chest,
October 1, 2009;
136(4):
1101 - 1111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Bedient, M. I. Schwarz, S. D. Groshong, and E. D. Chan
A 45-Year-Old Man With a History of Hepatitis C and Testicular Cancer Presents With Cavitary Lung Lesions and Palpable Purpura
Chest,
October 1, 2009;
136(4):
1168 - 1174.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B Terrier, D Saadoun, D Sene, P Ghillani, Z Amoura, G Deray, B Fautrel, J-C Piette, and P Cacoub
Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides
Ann Rheum Dis,
October 1, 2009;
68(10):
1564 - 1571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Kuligowski, R. Y. Q. Kwan, C. Lo, C. Wong, W. G. James, D. Bourges, J. D. Ooi, L. D. Abeynaike, P. Hall, A. R. Kitching, et al.
Antimyeloperoxidase antibodies rapidly induce {alpha}4-integrin-dependent glomerular neutrophil adhesion
Blood,
June 18, 2009;
113(25):
6485 - 6494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Little, L. Smyth, A. D. Salama, S. Mukherjee, J. Smith, D. Haskard, S. Nourshargh, H. T. Cook, and C. D. Pusey
Experimental Autoimmune Vasculitis: An Animal Model of Anti-neutrophil Cytoplasmic Autoantibody-Associated Systemic Vasculitis
Am. J. Pathol.,
April 1, 2009;
174(4):
1212 - 1220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Schreiber, H. Xiao, J. C. Jennette, W. Schneider, F. C. Luft, and R. Kettritz
C5a Receptor Mediates Neutrophil Activation and ANCA-Induced Glomerulonephritis
J. Am. Soc. Nephrol.,
February 1, 2009;
20(2):
289 - 298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Nolan, N. Kalia, G. B. Nash, D. Kamel, P. Heeringa, and C. O.S. Savage
Mechanisms of ANCA-Mediated Leukocyte-Endothelial Cell Interactions In Vivo
J. Am. Soc. Nephrol.,
May 1, 2008;
19(5):
973 - 984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A.F. de Lind van Wijngaarden, L. van Rijn, E. C. Hagen, R. A. Watts, G. Gregorini, J. W. C. Tervaert, A. D. Mahr, J. L. Niles, E. de Heer, J. A. Bruijn, et al.
Hypotheses on the Etiology of Antineutrophil Cytoplasmic Autoantibody Associated Vasculitis: The Cause Is Hidden, but the Result Is Known
Clin. J. Am. Soc. Nephrol.,
January 1, 2008;
3(1):
237 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. M van der Geld, T. Hellmark, D. Selga, P. Heeringa, M. G Huitema, P. C Limburg, and C. G M Kallenberg
Rats and mice immunised with chimeric human/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytes
Ann Rheum Dis,
December 1, 2007;
66(12):
1679 - 1682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lionaki and R. J. Falk
Removing Antibody and Preserving Glomeruli in ANCA Small-Vessel Vasculitis
J. Am. Soc. Nephrol.,
July 1, 2007;
18(7):
1987 - 1989.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R.W. Jayne, G. Gaskin, N. Rasmussen, D. Abramowicz, F. Ferrario, L. Guillevin, E. Mirapeix, C. O.S. Savage, R. A. Sinico, C. A. Stegeman, et al.
Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal Vasculitis
J. Am. Soc. Nephrol.,
July 1, 2007;
18(7):
2180 - 2188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Colman, A. Hussain, M. Goodall, S. P Young, T. Pankhurst, X. Lu, R. Jefferis, C. O S Savage, and J. M Williams
Chimeric antibodies to proteinase 3 of IgG1 and IgG3 subclasses induce different magnitudes of functional responses in neutrophils
Ann Rheum Dis,
May 1, 2007;
66(5):
676 - 682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Xiao, A. Schreiber, P. Heeringa, R. J. Falk, and J. C. Jennette
Alternative Complement Pathway in the Pathogenesis of Disease Mediated by Anti-Neutrophil Cytoplasmic Autoantibodies
Am. J. Pathol.,
January 1, 2007;
170(1):
52 - 64.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Schreiber, H. Xiao, R. J. Falk, and J. C. Jennette
Bone Marrow-Derived Cells Are Sufficient and Necessary Targets to Mediate Glomerulonephritis and Vasculitis Induced by Anti-Myeloperoxidase Antibodies
J. Am. Soc. Nephrol.,
December 1, 2006;
17(12):
3355 - 3364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Huugen, J. W. Cohen Tervaert, and P. Heeringa
TNF-{alpha} Bioactivity-Inhibiting Therapy in ANCA-Associated Vasculitis: Clinical and Experimental Considerations
Clin. J. Am. Soc. Nephrol.,
September 1, 2006;
1(5):
1100 - 1107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-J. Ruth, A. R. Kitching, R. Y.Q. Kwan, D. Odobasic, J. D.K. Ooi, J. R. Timoshanko, M. J. Hickey, and S. R. Holdsworth
Anti-Neutrophil Cytoplasmic Antibodies and Effector CD4+ Cells Play Nonredundant Roles in Anti-Myeloperoxidase Crescentic Glomerulonephritis
J. Am. Soc. Nephrol.,
July 1, 2006;
17(7):
1940 - 1949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Morgan, L. Harper, J. Williams, and C. Savage
Anti-Neutrophil Cytoplasm-Associated Glomerulonephritis
J. Am. Soc. Nephrol.,
May 1, 2006;
17(5):
1224 - 1234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Jennette, H. Xiao, and R. J. Falk
Pathogenesis of Vascular Inflammation by Anti-Neutrophil Cytoplasmic Antibodies
J. Am. Soc. Nephrol.,
May 1, 2006;
17(5):
1235 - 1242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Feldmann and C. D. Pusey
Is There a Role for TNF-{alpha} in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis? Lessons from Other Chronic Inflammatory Diseases
J. Am. Soc. Nephrol.,
May 1, 2006;
17(5):
1243 - 1252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Pusey
The Continuing Challenge of Anti-Neutrophil Cytoplasm Antibody-Associated Systemic Vasculitis and Glomerulonephritis
J. Am. Soc. Nephrol.,
May 1, 2006;
17(5):
1221 - 1223.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Little, G. Bhangal, C. L. Smyth, M. T. Nakada, H. T. Cook, S. Nourshargh, and C. D. Pusey
Therapeutic Effect of Anti-TNF-{alpha} Antibodies in an Experimental Model of Anti-Neutrophil Cytoplasm Antibody-Associated Systemic Vasculitis
J. Am. Soc. Nephrol.,
January 1, 2006;
17(1):
160 - 169.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|